Home › Therapeutic areas › Oncology › T-Cell Lymphoma
T-Cell Lymphoma (3 companies)
Companies with an active program in T-Cell Lymphoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics | GI/HepatologyOncology Rare | 1 | Phase 2 | $61.4M | 9 |
| ARTV | Artiva Biotherapeutics | Oncology | 1 | Phase 1 | $191M | 6 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | $3.90B | 9 |
No companies match.